Cannabis Stock News Daily Roundup September 13

Core One Labs (CSE: COOL) (OTCQX: LDSYD) (Frankfurt: LD6, WKN: A14XHT) said that its LDS Development subsidiary has received grading permits and broke ground on the Highway 395 Dispensary project in California. The project represents the final tier of the vertical integration for Core One from plant genetics, cultivation, extraction, distillation, and manufacturing of cannabis products to direct delivery to the customer.

Story continues below

Nextleaf Solutions (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) reported that Nextleaf Labs Ltd. has received its standard processing licence from Health Canada. The licence allows the company to commercialize its intellectual property portfolio through the production of cannabis oils and concentrates.

Cansortium (CSE: TIUM), a provider of medical cannabis under the Fluent brand, has opened a new Fluent dispensary in a prime location in Cape Coral, Fla. The new 3,440 square-foot dispensary is the company’s 15th in Florida and is located in central Cape Coral at 103 SW 3rd Place.

Target Capital (TSXV/CSE: TCI) has made a strategic investment in Intev Technologies, a Brooklyn, New York-based hardware technology company and the maker of Zepto, the first credit card-sized vaporizer. Target purchased US$300,000 of 7.0% senior secured convertible debentures of Intev under an investment agreement.

Pure Global Cannabis (TSX.V: PURE) (OTC: PRCNF) (FRA: 1QShas received approval from Health Canada for the sale of cannabis oil products, including high cannabidiol and premium craft cultivars that will become available soon for medical and legal adult patients.

Zenabis Global (TSX: ZENA) (OTC: ZBISFhas entered into a supply agreement with the Ontario Cannabis Retail Corporation (OCS) to supply adult-use recreational cannabis to retailers throughout the province. Zenabis will begin supplying the OCS with 21 different, adult-use cannabis products under its premium Namaste and Blazery brands, in the third quarter of 2019.

An ad to help with our costs